BIOMAT Database Logo BIOMAT Database Logo

[Myasthenic syndrome induced by D-penicillamine. Danger of curarization]. 1980

Y Blanloeil, and D Baron, and F Nicolas

UI MeSH Term Description Entries
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D003473 Neuromuscular Nondepolarizing Agents Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. Curare-Like Agents,Curariform Drugs,Muscle Relaxants, Non-Depolarizing,Neuromuscular Blocking Agents, Competitive,Nondepolarizing Blockers,Agents, Curare-Like,Agents, Neuromuscular Nondepolarizing,Blockers, Nondepolarizing,Curare Like Agents,Drugs, Curariform,Muscle Relaxants, Non Depolarizing,Non-Depolarizing Muscle Relaxants,Nondepolarizing Agents, Neuromuscular
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Y Blanloeil, and D Baron, and F Nicolas
[3 cases of myasthenic syndrome induced by D-penicillamine].
November 1987, Bulletin des societes d'ophtalmologie de France,
Y Blanloeil, and D Baron, and F Nicolas
[Myasthenic syndrome--complication of D-penicillamine therapy].
January 1984, Zeitschrift fur arztliche Fortbildung,
Y Blanloeil, and D Baron, and F Nicolas
D-penicillamine and the ocular myasthenic syndrome.
October 1981, Annals of ophthalmology,
Y Blanloeil, and D Baron, and F Nicolas
[Myasthenic syndrome induced by D-penicillamine. Changes in serum levels of acetylcholine receptor antibodies].
May 1982, La Nouvelle presse medicale,
Y Blanloeil, and D Baron, and F Nicolas
[Myasthenic syndrome during treatment with D penicillamine. A recent case].
January 1977, Annales de medecine interne,
Y Blanloeil, and D Baron, and F Nicolas
Pemphigus-like syndrome induced by D-penicillamine.
July 1976, The British journal of dermatology,
Y Blanloeil, and D Baron, and F Nicolas
Nephrotic syndrome induced by D-penicillamine therapy.
January 1979, International urology and nephrology,
Y Blanloeil, and D Baron, and F Nicolas
D-Penicillamine--induced pemphigus syndrome.
March 1982, Journal of the American Academy of Dermatology,
Y Blanloeil, and D Baron, and F Nicolas
[D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)].
May 1981, La Nouvelle presse medicale,
Y Blanloeil, and D Baron, and F Nicolas
[Myasthenic syndrome during penicillamine treatment (author's transl)].
February 1978, Klinische Wochenschrift,
Copied contents to your clipboard!